Erratum to: A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia. [Eur. J. Neurosci., (2013), 37, 1669-1681. doi: 10.1111/ejn.12162];A dietary polyphenol resveratrol acts to provide neuroprotection in recurrent stroke models by regulating AMPK and SIRT1 signaling, thereby reducing energy requirements during ischemia

European Journal of Neuroscience

Volumn 37, Issue 10, 2013, Pages 1669-1681

  Wang, Li Mei ^a,b   Wang, Yong Jiu ^c   Cui, Min ^a   Luo, Wen Juan ^d   Wang, Xiao Ji ^e   Barber, Philip A ^b   Chen, Zhe Yu ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF CALGARY   (Canada)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d QINGDAO UNIVERSITY   (China)

^e JIANGXI SCIENCE AND TECHNOLOGY NORMAL UNIVERSITY   (China)

Author keywords

Intracellular ATP level; Recurrent stroke model; RSV neuroprotection; SIRT1 and AMPK signaling

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; GLUCOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE; OXYGEN; POLYPHENOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; SIRTUIN 1; SMALL INTERFERING RNA;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL ENERGY; CONTROLLED STUDY; DISEASE MODEL; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG LIVER LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 84878014129     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.13230     Document Type: Erratum

References (57)

1. Baur, J.A. & Sinclair, D.A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov., 5, 493-506.
2. Benjelloun, N., Renolleau, S., Represa, A., Ben-Ari, Y. & Charriaut-Marlangue, C. (1999) Inflammatory responses in the cerebral cortex after ischemia in the P7 neonatal rat. Stroke, 30, 1916-1923.
3. Borra, M.T., Smith, B.C. & Denu, J.M. (2005) Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem., 280, 17187-17195.
4. Bradamante, S., Barenghi, L., Piccinini, F., Bertelli, A.A., De Jonge, R., Beemster, P. & De Jong, J.W. (2003) Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur. J. Pharmacol., 465, 115-123.
5. Cantó, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P. & Auwerx, J. (2009) AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 23, 1056-1060.
6. Carling, D. (2004) The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci., 29, 18-24.
7. Chandratheva, A., Mehta, Z., Geraghty, O.C., Marquardt, L. & Rothwell, P.M. (2009) Population-based study of risk and predictors of stroke in the first few h after a TIA. Neurology, 72, 1941-1947.
8. Correia, M., Silva, M.R., Magalhaes, R., Guimaraes, L. & Silva, M.C. (2006) Transient ischemic attacks in rural and urban northern Portugal: incidence and short-term prognosis. Stroke, 37, 50-55.
9. Dal-Pan, A., Terrien, J., Pifferi, F., Botalla, R., Hardy, I., Marchal, J., Zahariev, A., Chery, I., Zizzari, P., Perret, M., Picq, J.L., Epelbaum, J., Blanc, S. & Aujard, F. (2011) Caloric restriction or resveratrol supplementation and ageing in a non-human primate: first-year outcome of the RESTRIKAL study in Microcebus murinus. Age (Dordr), 33, 15-31.
10. Das, M. & Das, D.K. (2010) Resveratrol and cardiovascular health. Mol. Aspects Med., 31, 503-512.
11. Dasgupta, B. & Milbrandt, J. (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. USA, 104, 7217-7222.
12. Della-Mortem, D., Dave, K.R., DeFazio, R.A., Bao, Y.C., Raval, A.P. & Perez-Pinzon, M.A. (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience, 159, 993-1002.
13. Domoki, F., Kis, B., Gáspár, T., Snipes, J.A., Parks, J.S., Bari, F. & Busija, D.W. (2009) Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am. J. Physiol. Cell Physiol., 296, 97-105.
14. Dong, W., Li, N., Gao, D., Zhen, H., Zhang, X. & Li, F. (2008) Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J. Vasc. Surg., 48, 709-714.
15. Dudley, J., Das, S., Mukherjee, S. & Das, D.K. (2012) Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J. Nutr. Biochem., 23, 852.
16. Ferrara, N., Rinaldi, B., Corbi, G., Conti, V., Stiuso, P., Boccuti, S., Rengo, G., Rossi, F. & Filippelli, A. (2008) Exercise training promotes SIRT1 activity in aged rats. Rejuv. Res., 11, 139-150.
17. Finkel, T., Deng, C.X. & Mostoslavsky, R. (2009) Recent progress in the biology and physiology of sirtuins. Nature, 460, 587-591.
18. Guarani, V., Deflorian, G., Franco, C.A., Krüger, M., Phng, L.K., Bentley, K., Toussaint, L., Dequiedt, F., Mostoslavsky, R., Schmidt, M.H., Zimmermann, B., Brandes, R.P., Mione, M., Westphal, C.H., Braun, T., Zeiher, A.M., Gerhardt, H., Dimmeler, S. & Potente, M. (2011) Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature, 473, 234-238.
19. Hardie, D.G. (2007) AMP-activated/SNF1 protein kinases: conserved energy. Nat. Rev. Mol. Cell Bio., 8, 774-785.
20. Huang, S.S., Tsai, M.C., Chih, C.L., Hung, L.M. & Tsai, S.K. (2001) Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci., 69, 1057-1065.
21. Imai, S., Johnson, F.B., Marciniak, R.A., McVey, M., Park, P.U. & Guarente, L. (2000) Sir2: an NAD-dependent histone deacetylase that connects chromatin silencing, metabolism, and aging. Cold Spring Harb. Symp., 65, 297-302.
22. Jäger, S., Handschin, C., St-Pierre, J. & Spiegelman, B.M. (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA, 17, 12017-12022.
23. Johnston, D.C. & Hill, M.D. (2004) The patient with transient cerebral ischemia: a golden opportunity for stroke prevention. CMAJ, 170, 1134-1137.
24. Kopp, P. (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur. J. Endocrinol., 138, 619-620.
25. La-Morte, D., Dave, K.R., DeFazio, R.A., Bao, Y.C., Raval, A.P. & Perez-Pinzon, M.A. (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience, 159, 993-1002.
26. Li, C., Yan, Z., Yang, J., Chen, H., Li, H., Jiang, Y. & Zhang, Z. (2010) Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats. Neurochem. Int., 56, 495-500.
27. Lin, T.N., He, Y.Y., Wu, G., Khan, M. & Hsu, C.Y. (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke, 24, 117-121.
28. Liu, C., Liang, B., Wang, Q., Wu, J. & Zou, M.H. (2010) Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin. J. Biol. Chem., 285, 15346-15355.
29. MacDougall, N.J., Amarasinghe, S. & Muir, K.W. (2009) Secondary prevention of stroke. Expert Rev. Cardiovasc. Ther., 7, 1103-1115.
30. Murayama, A., Ohmori, K., Fujimura, A., Minami, H., Yasuzawa-Tanaka, K., Kuroda, T., Oie, S., Daitoku, H., Okuwaki, M., Nagata, K., Fukamizu, A., Kimura, K., Shimizu, T. & Yanagisawa, J. (2008) Epigenetic control of rDNA loci in response to intracellular energy status. Cell, 133, 627-639.
31. Nakano, A., Kato, H., Watanabe, T., Min, K.D., Yamazaki, S., Asano, Y., Seguchi, O., Higo, S., Shintani, Y., Asanuma, H., Asakura, M., Minamino, T., Kaibuchi, K., Mochizuki, N., Kitakaze, M. & Takashima, S. (2010) AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat. Cell Biol., 12, 583-590.
32. Pallàs, M., Pizarro, J.G., Gutierrez-Cuesta, J., Crespo-Biel, N., Alvira, D., Tajes, M., Yeste-Velasco, M., Folch, J., Canudas, A.M., Sureda, F.X., Ferrer, I. & Camins, A. (2008) Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience, 154, 1388-1397.
33. Pallàs, M., Casadesús, G., Smith, M.A., Coto-Montes, A., Pelegri, C., Vilaplana, J. & Camins, A. (2009) Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr. Neurovasc. Res., 6, 70-81.
34. Paolucci, S., Antonucci, G., Troisi, E., Bragoni, M., Coiro, P. & De, A.D. (2003) Aging and stroke rehabilitation: a case-comparison study. Cerebrovasc. Dis., 15, 98-105.
35. Penumathsa, S.V. & Maulik, N. (2009) Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can. J. Physiol. Pharm., 87, 275-286.
36. Qiao, M., Zhao, Z., Barber, P.A., Foniok, T., Sun, S. & Tuor, U.I. (2009a) Development of a model of recurrent stroke consisting of a mild transient stroke followed by a second moderate stroke in rats. J. Neurosci. Meth., 184, 244-250.
37. Qiao, M., Meng, S., Foniok, T. & Tuor, U.I. (2009b) Mild cerebral hypoxia-ischemia produces a sub-acute transient inflammatory response that is less selective and prolonged after a substantial insult. Int. J. Dev. Neurosci., 27, 691-700.
38. Raval, A.P., Dave, K.R. & Pérez-Pinzón, M.A. (2006) Resveratrol mimics ischemic preconditioning in the brain. J. Cerebr. Blood F. Met., 26, 1141-1147.
39. Roquer, J., Rodriguez-Campello, A., Cuadrado-Godia, E., Vivanco-Hidalgo, R.M., Jimenez-Conde, J., Perich, X. & Ois, A. (2010) Acute brain MRI-DWI patterns and stroke recurrence after mild-moderate stroke. J. Neurol., 257, 947-953.
40. Rothwell, P.M. & Warlow, C.P. (2005) Timing of TIAs preceding stroke: time window for prevention is very short. Neurology, 64, 817-820.
41. Sakata, Y., Zhuang, H., Kwansa, H., Koehler, R.C. & Doré, S. (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol., 224, 325-329.
42. Shichita, T., Muto, G. & Yoshimura, A. (2011) T lymphocyte function in the delayed phase of ischemic brain injury. Inflamm. Regen., 31, 102-108.
43. Shin, J.A., Lee, H., Lim, Y.K., Koh, Y., Choi, J.H. & Park, E.M. (2010) Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J. Neuroimmunol., 227, 93-100.
44. Sinha, K., Chaudhary, G. & Gupta, Y.K. (2002) Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci., 71, 655-665.
45. Smith, J.M., Lunga, P., Story, D., Harris, N., Le Belle, J., James, M.F., Pickard, J.D. & Fawcett, J.W. (2007) Inosine promotes recovery of skilled motor function in a model of focal brain injury. Brain, 130, 915-925.
46. Spence, J.D. (2010) Secondary stroke prevention. Nat. Rev. Neurol., 6, 477-486.
47. Suwa, M., Nakano, H., Higaki, Y., Nakamura, T., Katsuta, S. & Kumagai, S. (2003) Increased wheel-running activity in the genetically skeletal muscle fast-twich fiber dominant rats. J. Appl. Physiol., 94, 185-192.
48. Troyano, A., Fernández, C., Sancho, P., de Blas, E. & Aller, P. (2001) Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation. J. Biol. Chem., 276, 47107-47115.
49. Tsai, S.K., Hung, L.M., Fu, Y.T., Cheng, H., Nien, M.W., Liu, H.Y., Zhang, F.B. & Huang, S.S. (2007) Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J. Vasc. Surg., 46, 346-353.
50. Turnley, A.M., Stapleton, D., Mann, R.J., Witters, L.A., Kemp, B.E. & Bartlett, P.F. (1999) Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J. Neurochem., 72, 1707-1716.
51. Walle, T. (2004) Absorption and metabolism of flavonoids. Free Radical Bio. Med., 36, 829-837.
52. Walle, T., Hsieh, F., DeLegge, M.H., Oatis, J.E. Jr. & Walle, U.K. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos., 32, 1377-1382.
53. Wood, J.G., Rogina, B., Lavu, S., Howitz, K., Helfand, S.L., Tatar, M. & Sinclair, D. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430, 686-689.
54. Yang, J., Liu, G.Y., Lu, D.L., Dai, F., Qian, Y.P., Jin, X.L. & Zhou, B. (2010) Hybrid-increased radical-scavenging activity of resveratrol derivatives by incorporating a chroman moiety of vitamin E. Chemistry, 16, 12808-12813.
55. Yi, C.O., Jeon, B.T., Shin, H.J., Jeong, E.A., Chang, K.C., Lee, J.E., Lee, D.H., Kim, H.J., Kang, S.S., Cho, G.J., Choi, W.S. & Roh, G.S. (2011) Resveratrol activates AMPK and suppresses LPS-induced NF-κB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anat. Cell Biol., 4, 194-203.
56. Yousuf, S., Atif, F., Ahmad, M., Hoda, N., Ishrat, T., Khan, B. & Islam, F. (2009) Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res., 23, 242-253.
57. Zhang, F., Liu, J. & Shi, J.S. (2011) Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur. J. Pharmacol., 636, 1-7.